Zimmer Biomet
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Zimmer Biomet sits in the top decile of US sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count).
Zimmer Biomet: 115 sponsored US clinical trials, 12 recruiting.
Zimmer Biomet sponsors 115 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 53 completed. 4 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Rheumatoid Arthritis, with 13 trials.
Top-decile sponsor footprint
Zimmer Biomet ranks in the top decile of sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
53 of 82 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (64.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
115 total, page 1 of 3
Zimmer Biomet-RibFix Titan
NCT07485829
Mymobility Knee ROM
NCT06863428
Z1 Hip System: Post-Market Clinical Follow Up Study
NCT07104279
MDR - Comprehensive Primary Revision Stems PMCF
NCT06788717
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
NCT05787821
Affixus Natural Nail System Humeral Nail PMCF
NCT05019664
Zimmer Biomet Shoulder Arthroplasty PMCF
NCT04984291
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
NCT04754087
Persona Revision Knee System Outcomes
NCT04821154
JuggerStitch Post Market Clinical Follow-up Study
NCT04228367
MDR - PMCF Study for Taperloc Complete Stems
NCT04028687
Clinical Outcomes Study of the Nexel Total Elbow
NCT02469662
Comprehensive SRS Regenerex Tissue Attachment
NCT06615739
Persona IQ Cohort Study
NCT06089291
Cemented vs Cementless Persona Keel RCT
NCT05630053
Embody Post-Market Clinical Follow-Up Study
NCT05735119
A.L.P.S. Clavicle Plating System PMCF
NCT05327959
Avenir Complete Post-Market Clinical Follow-Up Study
NCT04731077
Persona Ti-Nidium Post-Market Clinical Follow-up
NCT04817969
MDR - Biomet Cannulated Screws
NCT04002518
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
NCT03726554
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
NCT03626038
SCP Hip Outcomes Study
NCT03494660
Prospective G7 Dual Mobility Total Hip PMCF
NCT03308929
Persona Partial Knee Clinical Outcomes Study
NCT03034811
Persona Total Knee Arthroplasty Outcomes Study
NCT02255383
Zimmer Trabecular Metal Total Ankle PMCF
NCT02038140
Vivacit-E Post-market Follow-up Study
NCT03226808
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
NCT01542580
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
NCT01307384
Database Retrieval for the Comprehensive Shoulder
NCT03409718
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
NCT01480440
OsseoFit Stemless Shoulder System (Anatomic)
NCT07421245
ROSA® Hip System THA PMCF
NCT05497206
Infection Consortium Study#1
NCT06153446
MDR - Longevity IT Oblique and Offset Liners
NCT05980234
RibFix Advantage™ Post-Market Follow-Up
NCT05179005
RISC Panel Remnant Sample Collection
NCT05778162
PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm and JuggerLoc™ in the Shoulder
NCT05584553
PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow
NCT05519228
Embody Insertional Achilles Tendinopathy
NCT05998785
FastFrame Knee Spanning and Damage Control Kit PMCF
NCT04730739
ROSA Robot Used in Total Knee Replacement Post Market Study
NCT03969654
MDR - M/L Taper With Kinectiv Technology Stems and Necks
NCT04027140
MDR SureLock All-Suture Anchor
NCT04093700
MDR EZ Pass and Precision Flexible Reamer
NCT03914703
Clinical Outcomes in Patients Treated With SternaLock Blu
NCT03709693
N-Force Screws Augmented With N-Force Blue in Hip Fractures
NCT03807349
THP Hip Fracture Plating System Study
NCT03870477
A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
NCT03737149
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Therapeutic Areas
Where Zimmer Biomet enrollment is open (later-stage tilt)
12 recruiting of 115 indexed (10% open); 53 completed (46%).
Phase mix: 4 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Rheumatoid Arthritis (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Zimmer Biomet: open-pipeline peers nationwide
Peers matched on 115 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Zimmer Biomet sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 115 trials (± recruiting share)
- Medstar Health Research Institute · 115 trials · 20% recruiting
- Medtronic Cardiac Rhythm and Heart Failure · 115 trials · 2% recruiting
- Rockefeller University · 117 trials · 4% recruiting
- State University of New York - Upstate Medical University · 113 trials · 7% recruiting
Sponsors near 10% open enrollment (± trial volume)
- University of Mississippi Medical Center · 10% recruiting · 96 trials
- Vertex Pharmaceuticals Incorporated · 10% recruiting · 191 trials
- Alexion Pharmaceuticals · 10% recruiting · 162 trials
- SWOG Cancer Research Network · 10% recruiting · 270 trials
Related
What to do with this Zimmer Biomet page
115 registered trials is a research-attention snapshot, not an endorsement of Zimmer Biomet or any single study.
- 12 of Zimmer Biomet's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Rheumatoid Arthritis is the condition Zimmer Biomet studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rheumatoid Arthritis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Zimmer Biomet pipeline card: 115 registered trials from official public datasets.Report a data error.